Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 92

1.

Pathogenic variants in glutamyl-tRNAGln amidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder.

Friederich MW, Timal S, Powell CA, Dallabona C, Kurolap A, Palacios-Zambrano S, Bratkovic D, Derks TGJ, Bick D, Bouman K, Chatfield KC, Damouny-Naoum N, Dishop MK, Falik-Zaccai TC, Fares F, Fedida A, Ferrero I, Gallagher RC, Garesse R, Gilberti M, González C, Gowan K, Habib C, Halligan RK, Kalfon L, Knight K, Lefeber D, Mamblona L, Mandel H, Mory A, Ottoson J, Paperna T, Pruijn GJM, Rebelo-Guiomar PF, Saada A, Sainz B Jr, Salvemini H, Schoots MH, Smeitink JA, Szukszto MJ, Ter Horst HJ, van den Brandt F, van Spronsen FJ, Veltman JA, Wartchow E, Wintjes LT, Zohar Y, Fernández-Moreno MA, Baris HN, Donnini C, Minczuk M, Rodenburg RJ, Van Hove JLK.

Nat Commun. 2018 Oct 3;9(1):4065. doi: 10.1038/s41467-018-06250-w.

2.

Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo.

Gammage PA, Viscomi C, Simard ML, Costa ASH, Gaude E, Powell CA, Van Haute L, McCann BJ, Rebelo-Guiomar P, Cerutti R, Zhang L, Rebar EJ, Zeviani M, Frezza C, Stewart JB, Minczuk M.

Nat Med. 2018 Nov;24(11):1691-1695. doi: 10.1038/s41591-018-0165-9. Epub 2018 Sep 24.

PMID:
30250142
3.

The contribution of cholesterol and epigenetic changes to the pathophysiology of breast cancer.

Munir MT, Ponce C, Powell CA, Tarafdar K, Yanagita T, Choudhury M, Gollahon LS, Rahman SM.

J Steroid Biochem Mol Biol. 2018 Oct;183:1-9. doi: 10.1016/j.jsbmb.2018.05.001. Epub 2018 May 4. Review.

PMID:
29733910
4.

Correction to: Baseline and annual repeat rounds of screening: implications for optimal regimens of screening.

Henschke CI, Salvatore M, Cham M, Powell CA, DiFabrizio L, Flores R, Kaufman A, Eber C, Yip R, Yankelevitz DF; International Early Lung Cancer Action Program Investigators.

Eur Radiol. 2018 Jul;28(7):3114. doi: 10.1007/s00330-017-5234-9.

PMID:
29442132
5.

Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseases.

Bansal R, Nakagawa S, Yazdani S, van Baarlen J, Venkatesh A, Koh AP, Song WM, Goossens N, Watanabe H, Beasley MB, Powell CA, Storm G, Kaminski N, van Goor H, Friedman SL, Hoshida Y, Prakash J.

Exp Mol Med. 2017 Nov 17;49(11):e396. doi: 10.1038/emm.2017.213.

6.

Baseline and annual repeat rounds of screening: implications for optimal regimens of screening.

Henschke CI, Salvatore M, Cham M, Powell CA, DiFabrizio L, Flores R, Kaufman A, Eber C, Yip R, Yankelevitz DF; International Early Lung Cancer Action Program Investigators.

Eur Radiol. 2018 Mar;28(3):1085-1094. doi: 10.1007/s00330-017-5029-z. Epub 2017 Oct 5. Erratum in: Eur Radiol. 2018 Feb 13;:.

PMID:
28983713
7.

Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement.

Mazzone PJ, Sears CR, Arenberg DA, Gaga M, Gould MK, Massion PP, Nair VS, Powell CA, Silvestri GA, Vachani A, Wiener RS; ATS Assembly on Thoracic Oncology.

Am J Respir Crit Care Med. 2017 Oct 1;196(7):e15-e29. doi: 10.1164/rccm.201708-1678ST.

8.

Probability of cancer in high-risk patients predicted by the protein-based lung cancer biomarker panel in China: LCBP study.

Yang D, Zhang X, Powell CA, Ni J, Wang B, Zhang J, Zhang Y, Wang L, Xu Z, Zhang L, Wu G, Song Y, Tian W, Hu JA, Zhang Y, Hu J, Hong Q, Song Y, Zhou J, Bai C.

Cancer. 2018 Jan 15;124(2):262-270. doi: 10.1002/cncr.31020. Epub 2017 Sep 20.

9.

Lung Cancer Diagnosis by Fine Needle Aspiration Is Associated With Reduction in Resection of Nonmalignant Lung Nodules.

Barta JA, Henschke CI, Flores RM, Yip R, Yankelevitz DF, Powell CA.

Ann Thorac Surg. 2017 Jun;103(6):1795-1801. doi: 10.1016/j.athoracsur.2016.11.055. Epub 2017 Mar 6.

PMID:
28274517
10.

Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017.

MacMahon H, Naidich DP, Goo JM, Lee KS, Leung ANC, Mayo JR, Mehta AC, Ohno Y, Powell CA, Prokop M, Rubin GD, Schaefer-Prokop CM, Travis WD, Van Schil PE, Bankier AA.

Radiology. 2017 Jul;284(1):228-243. doi: 10.1148/radiol.2017161659. Epub 2017 Feb 23.

PMID:
28240562
11.

COUNTERPOINT: Should Only Primary Care Physicians Provide Shared Decision-making Services to Discuss the Risks/Benefits of a Low-Dose Chest CT Scan for Lung Cancer Screening? No.

Powell CA.

Chest. 2017 Jun;151(6):1215-1217. doi: 10.1016/j.chest.2016.11.055. Epub 2016 Dec 29. No abstract available.

PMID:
28041887
12.

Pulmonary Infiltrates in a Patient With Advanced Melanoma.

Powell CA.

J Clin Oncol. 2017 Mar;35(7):705-708. doi: 10.1200/JCO.2016.69.9793. Epub 2016 Dec 28. Review.

PMID:
28029320
13.

Update in Lung Cancer 2015.

Spira A, Halmos B, Powell CA.

Am J Respir Crit Care Med. 2016 Sep 15;194(6):661-71. doi: 10.1164/rccm.201604-0898UP. No abstract available.

14.

The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.

Travis WD, Asamura H, Bankier AA, Beasley MB, Detterbeck F, Flieder DB, Goo JM, MacMahon H, Naidich D, Nicholson AG, Powell CA, Prokop M, Rami-Porta R, Rusch V, van Schil P, Yatabe Y; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and Advisory Board Members.

J Thorac Oncol. 2016 Aug;11(8):1204-1223. doi: 10.1016/j.jtho.2016.03.025. Epub 2016 Apr 21. Review.

15.

Endothelial Robo4 suppresses breast cancer growth and metastasis through regulation of tumor angiogenesis.

Zhao H, Ahirwar DK, Oghumu S, Wilkie T, Powell CA, Nasser MW, Satoskar AR, Li DY, Ganju RK.

Mol Oncol. 2016 Feb;10(2):272-81. doi: 10.1016/j.molonc.2015.10.007. Epub 2015 Oct 28.

16.

Lung inflammation promotes metastasis through neutrophil protease-mediated degradation of Tsp-1.

El Rayes T, Catena R, Lee S, Stawowczyk M, Joshi N, Fischbach C, Powell CA, Dannenberg AJ, Altorki NK, Gao D, Mittal V.

Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):16000-5. doi: 10.1073/pnas.1507294112. Epub 2015 Dec 14.

17.

An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice.

Wiener RS, Gould MK, Arenberg DA, Au DH, Fennig K, Lamb CR, Mazzone PJ, Midthun DE, Napoli M, Ost DE, Powell CA, Rivera MP, Slatore CG, Tanner NT, Vachani A, Wisnivesky JP, Yoon SH; ATS/ACCP Committee on Low-Dose CT Lung Cancer Screening in Clinical Practice.

Am J Respir Crit Care Med. 2015 Oct 1;192(7):881-91. doi: 10.1164/rccm.201508-1671ST.

18.

The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.

Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E, Flieder DB, Geisinger K, Hirsch FR, Ishikawa Y, Kerr KM, Noguchi M, Pelosi G, Powell CA, Tsao MS, Wistuba I; WHO Panel.

J Thorac Oncol. 2015 Sep;10(9):1243-1260. doi: 10.1097/JTO.0000000000000630.

19.

An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management.

Slatore CG, Horeweg N, Jett JR, Midthun DE, Powell CA, Wiener RS, Wisnivesky JP, Gould MK; ATS Ad Hoc Committee on Setting a Research Framework for Pulmonary Nodule Evaluation.

Am J Respir Crit Care Med. 2015 Aug 15;192(4):500-14. doi: 10.1164/rccm.201506-1082ST.

20.

Limited Resection Versus Lobectomy for Older Patients With Early-Stage Lung Cancer: Impact of Histology.

Veluswamy RR, Ezer N, Mhango G, Goodman E, Bonomi M, Neugut AI, Swanson S, Powell CA, Beasley MB, Wisnivesky JP.

J Clin Oncol. 2015 Oct 20;33(30):3447-53. doi: 10.1200/JCO.2014.60.6624. Epub 2015 Aug 3.

21.

Update in Lung Cancer 2014.

Spira A, Halmos B, Powell CA.

Am J Respir Crit Care Med. 2015 Aug 1;192(3):283-94. doi: 10.1164/rccm.201504-0756UP. Review.

22.

Outcomes after Stereotactic Body Radiotherapy versus Limited Resection in Older Patients with Early-Stage Lung Cancer.

Ezer N, Veluswamy RR, Mhango G, Rosenzweig KE, Powell CA, Wisnivesky JP.

J Thorac Oncol. 2015 Aug;10(8):1201-6. doi: 10.1097/JTO.0000000000000600.

23.

Integrating a Parenting Intervention With Routine Primary Health Care: A Cluster Randomized Trial.

Chang SM, Grantham-McGregor SM, Powell CA, Vera-Hernández M, Lopez-Boo F, Baker-Henningham H, Walker SP.

Pediatrics. 2015 Aug;136(2):272-80. doi: 10.1542/peds.2015-0119. Epub 2015 Jul 6.

24.

Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability.

Powell CA, Nasser MW, Zhao H, Wochna JC, Zhang X, Shapiro C, Shilo K, Ganju RK.

Oncotarget. 2015 Mar 20;6(8):6373-85.

25.

RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment.

Nasser MW, Wani NA, Ahirwar DK, Powell CA, Ravi J, Elbaz M, Zhao H, Padilla L, Zhang X, Shilo K, Ostrowski M, Shapiro C, Carson WE 3rd, Ganju RK.

Cancer Res. 2015 Mar 15;75(6):974-85. doi: 10.1158/0008-5472.CAN-14-2161. Epub 2015 Jan 8.

26.

The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome.

Remark R, Becker C, Gomez JE, Damotte D, Dieu-Nosjean MC, Sautès-Fridman C, Fridman WH, Powell CA, Altorki NK, Merad M, Gnjatic S.

Am J Respir Crit Care Med. 2015 Feb 15;191(4):377-90. doi: 10.1164/rccm.201409-1671PP. Review.

27.

Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement.

Mazzone P, Powell CA, Arenberg D, Bach P, Detterbeck F, Gould MK, Jaklitsch MT, Jett J, Naidich D, Vachani A, Wiener RS, Silvestri G.

Chest. 2015 Feb;147(2):295-303. doi: 10.1378/chest.14-2500.

28.

MODMatcher: multi-omics data matcher for integrative genomic analysis.

Yoo S, Huang T, Campbell JD, Lee E, Tu Z, Geraci MW, Powell CA, Schadt EE, Spira A, Zhu J.

PLoS Comput Biol. 2014 Aug 14;10(8):e1003790. doi: 10.1371/journal.pcbi.1003790. eCollection 2014 Aug.

29.

Molecular testing guidelines for lung adenocarcinoma: Utility of cell blocks and concordance between fine-needle aspiration cytology and histology samples.

Heymann JJ, Bulman WA, Maxfield RA, Powell CA, Halmos B, Sonett J, Beaubier NT, Crapanzano JP, Mansukhani MM, Saqi A.

Cytojournal. 2014 May 22;11:12. doi: 10.4103/1742-6413.132989. eCollection 2014.

30.

CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model.

Oghumu S, Varikuti S, Terrazas C, Kotov D, Nasser MW, Powell CA, Ganju RK, Satoskar AR.

Immunology. 2014 Sep;143(1):109-19. doi: 10.1111/imm.12293.

31.

An official American Thoracic Society/European Respiratory Society statement: the role of the pulmonologist in the diagnosis and management of lung cancer.

Gaga M, Powell CA, Schraufnagel DE, Schönfeld N, Rabe K, Hill NS, Sculier JP; ATS/ERS Task Force on the Role of the Pulmonologist in the Management of Lung Cancer.

Am J Respir Crit Care Med. 2013 Aug 15;188(4):503-7. doi: 10.1164/rccm.201307-1269ST.

32.

Update in lung cancer and mesothelioma 2012.

Powell CA, Halmos B, Nana-Sinkam SP.

Am J Respir Crit Care Med. 2013 Jul 15;188(2):157-66. doi: 10.1164/rccm.201304-0716UP. Review. No abstract available.

33.
34.

PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells.

Cheng H, Zhang Z, Borczuk A, Powell CA, Balajee AS, Lieberman HB, Halmos B.

Carcinogenesis. 2013 Apr;34(4):739-49. doi: 10.1093/carcin/bgs393. Epub 2012 Dec 28.

35.

Evaluating beliefs associated with late-stage lung cancer presentation in minorities.

Bergamo C, Lin JJ, Smith C, Lurslurchachai L, Halm EA, Powell CA, Berman A, Schicchi JS, Keller SM, Leventhal H, Wisnivesky JP.

J Thorac Oncol. 2013 Jan;8(1):12-8. doi: 10.1097/JTO.0b013e3182762ce4.

36.

Thymidylate synthase expression and molecular alterations in adenosquamous carcinoma of the lung.

Shu C, Cheng H, Wang A, Mansukhani MM, Powell CA, Halmos B, Borczuk AC.

Mod Pathol. 2013 Feb;26(2):239-46. doi: 10.1038/modpathol.2012.158. Epub 2012 Sep 21.

37.

Racial and ethnic differences in beliefs about lung cancer care.

Jonnalagadda S, Lin JJ, Nelson JE, Powell CA, Salazar-Schicchi J, Berman AR, Keller SM, Smith CB, Lurslurchachai L, Halm EA, Leventhal H, Wisnivesky JP.

Chest. 2012 Nov;142(5):1251-1258. doi: 10.1378/chest.12-0330.

38.

S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.

Nasser MW, Qamri Z, Deol YS, Ravi J, Powell CA, Trikha P, Schwendener RA, Bai XF, Shilo K, Zou X, Leone G, Wolf R, Yuspa SH, Ganju RK.

Cancer Res. 2012 Feb 1;72(3):604-15. doi: 10.1158/0008-5472.CAN-11-0669. Epub 2011 Dec 12.

39.

Acquisition and processing of endobronchial ultrasound-guided transbronchial needle aspiration specimens in the era of targeted lung cancer chemotherapy.

Bulman W, Saqi A, Powell CA.

Am J Respir Crit Care Med. 2012 Mar 15;185(6):606-11. doi: 10.1164/rccm.201107-1199CI. Epub 2011 Oct 27. Review.

40.

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary.

Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, Powell CA, Beer D, Riely G, Garg K, Austin JH, Rusch VW, Hirsch FR, Jett J, Yang PC, Gould M; American Thoracic Society.

Proc Am Thorac Soc. 2011 Sep;8(5):381-5. doi: 10.1513/pats.201107-042ST.

PMID:
21926387
41.

Progression of human bronchioloalveolar carcinoma to invasive adenocarcinoma is modeled in a transgenic mouse model of K-ras-induced lung cancer by loss of the TGF-β type II receptor.

Borczuk AC, Sole M, Lu P, Chen J, Wilgus ML, Friedman RA, Albelda SM, Powell CA.

Cancer Res. 2011 Nov 1;71(21):6665-75. doi: 10.1158/0008-5472.CAN-11-1590. Epub 2011 Sep 12.

42.

Update in lung cancer and oncological disorders 2010.

Halmos B, Powell CA.

Am J Respir Crit Care Med. 2011 Aug 1;184(3):297-302. doi: 10.1164/rccm.201103-0370UP. No abstract available.

43.

Lung cancer physicians' referral practices for palliative care consultation.

Smith CB, Nelson JE, Berman AR, Powell CA, Fleischman J, Salazar-Schicchi J, Wisnivesky JP.

Ann Oncol. 2012 Feb;23(2):382-7. doi: 10.1093/annonc/mdr345. Epub 2011 Jul 29.

44.

Do all lung adenocarcinomas follow a stepwise progression?

Yatabe Y, Borczuk AC, Powell CA.

Lung Cancer. 2011 Oct;74(1):7-11. doi: 10.1016/j.lungcan.2011.05.021. Epub 2011 Jun 25. Review.

45.

Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survival.

Wilgus ML, Borczuk AC, Stoopler M, Ginsburg M, Gorenstein L, Sonett JR, Powell CA.

Cancer. 2011 May 15;117(10):2186-91. doi: 10.1002/cncr.25768. Epub 2010 Nov 29.

46.

Patients rate physician communication about lung cancer.

Nelson JE, Gay EB, Berman AR, Powell CA, Salazar-Schicchi J, Wisnivesky JP.

Cancer. 2011 Nov 15;117(22):5212-20. doi: 10.1002/cncr.26152. Epub 2011 Apr 14.

47.

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D.

J Thorac Oncol. 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221. Review.

48.

Molecular testing in lung cancer: the time is now.

Cheng H, Xu X, Costa DB, Powell CA, Halmos B.

Curr Oncol Rep. 2010 Sep;12(5):335-48. doi: 10.1007/s11912-010-0118-z. Review.

PMID:
20623207
49.

Computer-aided diagnosis of pulmonary nodules using a two-step approach for feature selection and classifier ensemble construction.

Lee MC, Boroczky L, Sungur-Stasik K, Cann AD, Borczuk AC, Kawut SM, Powell CA.

Artif Intell Med. 2010 Sep;50(1):43-53. doi: 10.1016/j.artmed.2010.04.011. Epub 2010 May 31.

PMID:
20570118
50.

Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift.

Travis WD, Rekhtman N, Riley GJ, Geisinger KR, Asamura H, Brambilla E, Garg K, Hirsch FR, Noguchi M, Powell CA, Rusch VW, Scagliotti G, Yatabe Y.

J Thorac Oncol. 2010 Apr;5(4):411-4. doi: 10.1097/JTO.0b013e3181d57f6e. No abstract available.

51.

Tgf-beta signaling pathway in lung adenocarcinoma invasion.

Toonkel RL, Borczuk AC, Powell CA.

J Thorac Oncol. 2010 Feb;5(2):153-7. doi: 10.1097/JTO.0b013e3181c8cc0c. Review.

52.

Rounding up apoptosis resistance targets in lung cancer.

Powell CA.

Am J Respir Cell Mol Biol. 2009 Jul;41(1):7-8. doi: 10.1165/rcmb.2009-0002ED. No abstract available.

PMID:
19525385
53.

Update in lung cancer 2008.

Dubey S, Powell CA.

Am J Respir Crit Care Med. 2009 May 15;179(10):860-8. doi: 10.1164/rccm.200902-0289UP. Review. No abstract available.

54.

Genomics of lung cancer.

Borczuk AC, Toonkel RL, Powell CA.

Proc Am Thorac Soc. 2009 Apr 15;6(2):152-8. doi: 10.1513/pats.200807-076LC. Review.

55.

Invasive size is an independent predictor of survival in pulmonary adenocarcinoma.

Borczuk AC, Qian F, Kazeros A, Eleazar J, Assaad A, Sonett JR, Ginsburg M, Gorenstein L, Powell CA.

Am J Surg Pathol. 2009 Mar;33(3):462-9. doi: 10.1097/PAS.0b013e318190157c.

56.

Carcinoma of the lung and metastatic disease of the central nervous system.

Austin JH, Mujoomdar A, Powell CA, Pearson GD, Raftopoulos H.

Am J Respir Crit Care Med. 2008 Nov 15;178(10):1090; author reply 1090. No abstract available.

PMID:
18987348
57.

Plasma carbonyls do not correlate with lung function or computed tomography measures of lung density in older smokers.

Mesia-Vela S, Yeh CC, Austin JH, Dounel M, Powell CA, Reeves A, Santella RM, Stevenson L, Yankelevitz D, Barr RG.

Biomarkers. 2008 Jun;13(4):422-34. doi: 10.1080/13547500802002859 .

58.

Update in lung cancer 2007.

Dubey S, Powell CA.

Am J Respir Crit Care Med. 2008 May 1;177(9):941-6. doi: 10.1164/rccm.200801-107UP. Review. No abstract available.

59.

Waiting to exhale.

Powell CA.

Am J Respir Crit Care Med. 2008 Feb 1;177(3):246-7. doi: 10.1164/rccm.200710-1604ED. No abstract available.

PMID:
18219056
60.

No effect of cigarette smoking dose on oxidized plasma proteins.

Yeh CC, Barr RG, Powell CA, Mesia-Vela S, Wang Y, Hamade NK, Austin JH, Santella RM.

Environ Res. 2008 Feb;106(2):219-25. Epub 2007 Nov 9.

61.

17HSD 2 may be higher in African-American breast cancer and is associated with estrogen receptor-negative tumors.

Yaeger R, Nolan PC, Su T, Avila-Bront A, Wang X, Cheung YK, Liu H, Rangarajan VS, Hibshoosh H, Powell CA, Joe AK.

Cancer Genomics Proteomics. 2007 Sep-Oct;4(5):341-8.

62.

Lung adenocarcinoma invasion in TGFbetaRII-deficient cells is mediated by CCL5/RANTES.

Borczuk AC, Papanikolaou N, Toonkel RL, Sole M, Gorenstein LA, Ginsburg ME, Sonett JR, Friedman RA, Powell CA.

Oncogene. 2008 Jan 17;27(4):557-64. Epub 2007 Jul 23.

63.

A 10-gene classifier for distinguishing head and neck squamous cell carcinoma and lung squamous cell carcinoma.

Vachani A, Nebozhyn M, Singhal S, Alila L, Wakeam E, Muschel R, Powell CA, Gaffney P, Singh B, Brose MS, Litzky LA, Kucharczuk J, Kaiser LR, Marron JS, Showe MK, Albelda SM, Showe LC.

Clin Cancer Res. 2007 May 15;13(10):2905-15.

64.

Update in lung cancer 2006.

Dubey S, Powell CA.

Am J Respir Crit Care Med. 2007 May 1;175(9):868-74. Review. No abstract available.

65.

Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases.

Mujoomdar A, Austin JH, Malhotra R, Powell CA, Pearson GD, Shiau MC, Raftopoulos H.

Radiology. 2007 Mar;242(3):882-8. Epub 2007 Jan 17.

PMID:
17229875
66.

Expression profiling and lung cancer development.

Borczuk AC, Powell CA.

Proc Am Thorac Soc. 2007 Jan;4(1):127-32. Review.

PMID:
17202302
67.

Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors.

Borczuk AC, Cappellini GC, Kim HK, Hesdorffer M, Taub RN, Powell CA.

Oncogene. 2007 Jan 25;26(4):610-7. Epub 2006 Jul 24.

PMID:
16862182
68.

Epigenetic inactivation of Betaig-h3 gene in human cancer cells.

Shao G, Berenguer J, Borczuk AC, Powell CA, Hei TK, Zhao Y.

Cancer Res. 2006 May 1;66(9):4566-73.

69.

The Epithelial Cell in Lung Health and Emphysema Pathogenesis.

Mercer BA, Lemaître V, Powell CA, D'Armiento J.

Curr Respir Med Rev. 2006 May;2(2):101-142.

70.

Palatal neurofibroma associated with localized periodontitis.

Powell CA, Stanley CM, Bannister SR, McDonnell HT, Moritz AJ, Deas DE.

J Periodontol. 2006 Feb;77(2):310-5.

PMID:
16460259
71.

Structural emphysema does not correlate with lung compliance: lessons from the mouse smoking model.

Foronjy RF, Mercer BA, Maxfield MW, Powell CA, D'Armiento J, Okada Y.

Exp Lung Res. 2005 Jul-Aug;31(6):547-62.

PMID:
16019987
72.

Utility of CD138 (syndecan-1) in distinguishing carcinomas from mesotheliomas.

Saqi A, Yun SS, Yu GH, Alexis D, Taub RN, Powell CA, Borczuk AC.

Diagn Cytopathol. 2005 Aug;33(2):65-70.

PMID:
16007640
73.

Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness.

Borczuk AC, Kim HK, Yegen HA, Friedman RA, Powell CA.

Am J Respir Crit Care Med. 2005 Sep 15;172(6):729-37. Epub 2005 Jun 23.

74.

P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma.

Borczuk AC, Taub RN, Hesdorffer M, Hibshoosh H, Chabot JA, Keohan ML, Alsberry R, Alexis D, Powell CA.

Clin Cancer Res. 2005 May 1;11(9):3303-8.

75.

CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall.

Mazziotta RM, Borczuk AC, Powell CA, Mansukhani M.

Appl Immunohistochem Mol Morphol. 2005 Mar;13(1):55-60.

PMID:
15722794
76.

Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma.

Shah L, Walter KL, Borczuk AC, Kawut SM, Sonett JR, Gorenstein LA, Ginsburg ME, Steinglass KM, Powell CA.

Cancer. 2004 Oct 1;101(7):1632-8.

77.

Non-small cell lung cancer molecular profiles are associated with lung development.

Borczuk AC, Assaad AM, Wang LQ, Walter KL, Powell CA.

Chest. 2004 May;125(5 Suppl):115S-6S. No abstract available.

PMID:
15136454
78.

Class prediction of lung nodule gene expression profiles.

Walter KL, Borczuk AC, Wang LQ, Assaad AM, Austin JH, Pearson GD, Shiau MC, Powell CA.

Chest. 2004 May;125(5 Suppl):104S. No abstract available.

PMID:
15136440
79.

Molecular signatures in biopsy specimens of lung cancer.

Borczuk AC, Shah L, Pearson GD, Walter KL, Wang L, Austin JH, Friedman RA, Powell CA.

Am J Respir Crit Care Med. 2004 Jul 15;170(2):167-74. Epub 2004 Apr 15.

PMID:
15087295
80.

Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways.

Borczuk AC, Gorenstein L, Walter KL, Assaad AA, Wang L, Powell CA.

Am J Pathol. 2003 Nov;163(5):1949-60.

81.

The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor.

Kim H, Xu GL, Borczuk AC, Busch S, Filmus J, Capurro M, Brody JS, Lange J, D'Armiento JM, Rothman PB, Powell CA.

Am J Respir Cell Mol Biol. 2003 Dec;29(6):694-701. Epub 2003 Jun 19.

PMID:
12816733
82.

Gene expression in lung adenocarcinomas of smokers and nonsmokers.

Powell CA, Spira A, Derti A, DeLisi C, Liu G, Borczuk A, Busch S, Sahasrabudhe S, Chen Y, Sugarbaker D, Bueno R, Richards WG, Brody JS.

Am J Respir Cell Mol Biol. 2003 Aug;29(2):157-62. Epub 2003 Feb 21.

PMID:
12600827
83.

Patterns of allelic loss differ in lung adenocarcinomas of smokers and nonsmokers.

Powell CA, Bueno R, Borczuk AC, Caracta CF, Richards WG, Sugarbaker DJ, Brody JS.

Lung Cancer. 2003 Jan;39(1):23-9.

PMID:
12499090
84.

Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition.

Li CM, Guo M, Borczuk A, Powell CA, Wei M, Thaker HM, Friedman R, Klein U, Tycko B.

Am J Pathol. 2002 Jun;160(6):2181-90.

85.

Oligonucleotide microarray analysis of lung adenocarcinoma in smokers and nonsmokers identifies GPC3 as a potential lung tumor suppressor.

Powell CA, Xu G, Filmus J, Busch S, Brody JS, Rothman PB.

Chest. 2002 Mar;121(3 Suppl):6S-7S. No abstract available.

PMID:
11893651
86.

Pulmonary function tests in preoperative pulmonary evaluation.

Powell CA, Caplan CE.

Clin Chest Med. 2001 Dec;22(4):703-14, viii. Review.

PMID:
11787660
87.

Loss of heterozygosity in epithelial cells obtained by bronchial brushing: clinical utility in lung cancer.

Powell CA, Klares S, O'Connor G, Brody JS.

Clin Cancer Res. 1999 Aug;5(8):2025-34.

88.
89.

Results of case-control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria.

Gardner MJ, Snee MP, Hall AJ, Powell CA, Downes S, Terrell JD.

BMJ. 1990 Feb 17;300(6722):423-9. Erratum in: BMJ. 1992 Sep 19;305(6855):715.

90.

Continuing high lung cancer mortality among ex-amosite asbestos factory workers and a pilot study of individual anti-smoking advice.

Gardner MJ, Powell CA, Gardner AW, Winter PD, Fletcher AC.

J Soc Occup Med. 1988 Autumn;38(3):69-72. No abstract available.

PMID:
2902246
91.

Follow up study of workers manufacturing chrysotile asbestos cement products.

Gardner MJ, Winter PD, Pannett B, Powell CA.

Br J Ind Med. 1986 Nov;43(11):726-32.

92.

Mortality of asbestos cement workers using almost exclusively chrysotile fibre.

Gardner MJ, Powell CA.

J Soc Occup Med. 1986 Winter;36(4):124-6. No abstract available.

PMID:
3027452

Supplemental Content

Loading ...
Support Center